Literature DB >> 17449720

Biochemical consequences of the NOS3 Glu298Asp variation in human endothelium: altered caveolar localization and impaired response to shear.

Mandar S Joshi1, Chieko Mineo, Philip W Shaul, John Anthony Bauer.   

Abstract

Human endothelial nitric oxide synthase (NOS3) gene polymorphism at Exon 7 (Glu298Asp) has been linked to vascular endothelial dysfunction, but the mechanisms are not defined. Shear is a key modulator of NOS3 function in vivo and association with caveolae is important for the control of NOS3 protein activity. Here we tested the hypothesis that altered enrichment of NOS3 in the caveolar membrane defines Glu298Asp genotype-specific responses and NOS3 activity. Basal caveolar membrane enrichment was carried out to quantitate the NOS3 enrichment in caveolae. Cells were subjected to shear and NOS3 protein levels, phosphorylation, enzyme function were investigated. Variant genotypes had lower NOx production pre- and post-shear, but no genotype-dependent alterations in pNOS3 were observed. Asp variants had significantly lower NOS3 enrichment in the caveolar membrane fraction. Further, immunoprecipitation studies demonstrated that Asp variants had substantially less NOS3/Cav-1 association (approximately 40%) during static conditions. Furthermore, acute shear causes impaired NOS3/Cav-1 dissociation in Asp variants. The results from immunoprecipitation studies were in complete agreement with caveolar membrane preparation findings. Collectively, these data demonstrate functional consequences of the Glu298Asp NOS3 variation and further define disruption of NOS3 caveolar localization and shear-induced mobilization as the primary mechanism responsible for these differences.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17449720     DOI: 10.1096/fj.06-7088com

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  22 in total

1.  The 894G>T endothelial nitric oxide synthase genetic polymorphism affects hemodynamic responses to mental stress performed before and after exercise.

Authors:  Natália Galito Rocha; Fabricia Junqueira Neves; Bruno Moreira Silva; Allan Robson Kluser Sales; Antonio Claudio Nóbrega
Journal:  Eur J Appl Physiol       Date:  2011-06-18       Impact factor: 3.078

2.  Influence of fat intake and BMI on the association of rs1799983 NOS3 polymorphism with blood pressure levels in an Iberian population.

Authors:  Leticia Goni; Marta Cuervo; Fermín I Milagro; J Alfredo Martínez
Journal:  Eur J Nutr       Date:  2016-03-19       Impact factor: 5.614

Review 3.  Nitric oxide signalling in cardiovascular health and disease.

Authors:  Charlotte Farah; Lauriane Y M Michel; Jean-Luc Balligand
Journal:  Nat Rev Cardiol       Date:  2018-02-01       Impact factor: 32.419

4.  Endothelial nitric oxide synthase gene variation associated with chronic kidney disease after liver transplant.

Authors:  Kiran Bambha; W Ray Kim; Charles B Rosen; Rachel A Pedersen; Cynthia Rys; Christopher P Kolbert; Julie M Cunningham; Terry M Therneau
Journal:  Mayo Clin Proc       Date:  2010-09       Impact factor: 7.616

5.  eNOS and BDKRB2 genotypes affect the antihypertensive responses to enalapril.

Authors:  P S Silva; V Fontana; M R Luizon; R Lacchini; W A Silva; C Biagi; J E Tanus-Santos
Journal:  Eur J Clin Pharmacol       Date:  2012-06-17       Impact factor: 2.953

6.  Hypertension and longevity: role of genetic polymorphisms in renin-angiotensin-aldosterone system and endothelial nitric oxide synthase.

Authors:  Alda Pereira da Silva; Andreia Matos; Laura Aguiar; Nuno Ramos-Marques; Ricardo Ribeiro; Ângela Gil; João Gorjão-Clara; Manuel Bicho
Journal:  Mol Cell Biochem       Date:  2018-11-20       Impact factor: 3.396

7.  Fractional Flow Reserve Versus Instantaneous Wave-Free Ratio in Assessment of Lesion Hemodynamic Significance and Explanation of their Discrepancies. International, Multicenter and Prospective Trial: The FiGARO Study.

Authors:  Tomas Kovarnik; Matsuo Hitoshi; Ales Kral; Stepan Jerabek; David Zemanek; Yoshiaki Kawase; Hiroyuki Omori; Toru Tanigaki; Jan Pudil; Alexandra Vodzinska; Marian Branny; Roman Stipal; Petr Kala; Jan Mrozek; Martin Porzer; Tomas Grezl; Kamil Novobilsky; Oscar Mendiz; Karel Kopriva; Martin Mates; Martin Chval; Zhi Chen; Pavel Martasek; Ales Linhart
Journal:  J Am Heart Assoc       Date:  2022-05-03       Impact factor: 6.106

8.  Association of NOS3 Glu298Asp SNP with hypertension and possible effect modification of dietary fat intake in the ARIC study.

Authors:  Pascal L Kingah; Hung N Luu; Kelly A Volcik; Alanna C Morrison; Jennifer A Nettleton; Eric Boerwinkle
Journal:  Hypertens Res       Date:  2009-12-04       Impact factor: 3.872

9.  Systems Pharmacology Dissecting Holistic Medicine for Treatment of Complex Diseases: An Example Using Cardiocerebrovascular Diseases Treated by TCM.

Authors:  Yonghua Wang; Chunli Zheng; Chao Huang; Yan Li; Xuetong Chen; Ziyin Wu; Zhenzhong Wang; Wei Xiao; Boli Zhang
Journal:  Evid Based Complement Alternat Med       Date:  2015-05-26       Impact factor: 2.629

10.  Association between -T786C NOS3 polymorphism and resistant hypertension: a prospective cohort study.

Authors:  Ignacio Cruz-González; Esther Corral; María Sánchez-Ledesma; Angel Sánchez-Rodríguez; Cándido Martín-Luengo; Rogelio González-Sarmiento
Journal:  BMC Cardiovasc Disord       Date:  2009-08-04       Impact factor: 2.298

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.